These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. L-dopa induced dyskinesias in 152 patients with Parkinson's disease. Mones RJ; Elizan TS; Siegel G Trans Am Neurol Assoc; 1970; 95():286-7. PubMed ID: 5514393 [No Abstract] [Full Text] [Related]
5. The treatment of dystonia with L-dopa and haloperidol. Mandell S Neurology; 1970 Nov; 20(11):103-6. PubMed ID: 5529471 [No Abstract] [Full Text] [Related]
6. An analysis of L-dopa-induced dyskinesias in 152 cases of Parkinson's disease. Mones RJ; Elizan TS; Siegel GJ Neurology; 1970 Apr; 20(4):405-6. PubMed ID: 5535050 [No Abstract] [Full Text] [Related]
7. Levodopa-induced dyskinesias. Comparison in Parkinsonism-dementia and amyotrophic lateral sclerosis. Chase TN; Holden EM; Brody JA Arch Neurol; 1973 Nov; 29(5):328-33. PubMed ID: 4743883 [No Abstract] [Full Text] [Related]
8. Treatment of Parkinsonism with Laevo-dopa. Mawdsley C Br Med J; 1970 Feb; 1(5692):331-7. PubMed ID: 4906702 [TBL] [Abstract][Full Text] [Related]
9. Importance and pathogenesis of abnormal movements during L-dopa therapy of Parkinson's disease. Barbeau A Neurology; 1970 Apr; 20(4):377. PubMed ID: 5534982 [No Abstract] [Full Text] [Related]
10. Haloperidol in dopa-induced choreo-athetosis. Postma JU Psychiatr Neurol Neurochir; 1972; 75(1):69-71. PubMed ID: 5024898 [No Abstract] [Full Text] [Related]
11. Differentiation of tardive dyskinesias and drug-induced Parkinsonism. N Engl J Med; 1971 Jun; 284(24):1382-4. PubMed ID: 5576464 [No Abstract] [Full Text] [Related]
12. [Treatment of Parkinsonism with oral L-DOPA combined with a decarboxylase inhibitor (Ro IV 46.02)]. Tissot R; Gaillard JM; Guggisberg M; Gauthier G; de Ajuriaguerra J Presse Med (1893); 1969 Apr; 77(17):619-22. PubMed ID: 5785081 [No Abstract] [Full Text] [Related]
13. Laevo-dopa for Parkinsonism. Jenkins R Br Med J; 1970 May; 2(5705):361-2. PubMed ID: 5429465 [No Abstract] [Full Text] [Related]
16. Akinesis following stereotactic surgery for Parkinsonism. The use of L-dopa. Ahmad R; Gillingham FJ; Hanieh A; Pullar IA; Weddell J; Ashcroft G Confin Neurol; 1970; 32(2):128-34. PubMed ID: 4926177 [No Abstract] [Full Text] [Related]
17. Deanol in the treatment of levodopa-induced dyskinesias. Miller E Neurology; 1974 Feb; 24(2):116-9. PubMed ID: 4855678 [No Abstract] [Full Text] [Related]
18. [Abnormal movements observed during treatment of Parkinson's disease with L-dopa]. Sigwald J; Raymondeaud C Rev Neurol (Paris); 1970 Feb; 122(2):103-12. PubMed ID: 4397165 [No Abstract] [Full Text] [Related]
19. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism. Jenkins AC; Schwieger AC Med J Aust; 1971 Oct; 2(14):693-700. PubMed ID: 5114186 [No Abstract] [Full Text] [Related]
20. L-dopa in the treatment of parkinsonism. Haleem MA Gerontol Clin (Basel); 1972; 14(4):242-8. PubMed ID: 4634915 [No Abstract] [Full Text] [Related] [Next] [New Search]